We examined CITED2 expression in 28 different types of cancer using The Cancer Genome Atlas (TCGA) database and found relatively high CITED2 mRNA levels in thyroid, kidney, ovarian, lung, prostate, breast, and lung cancers (Fig. 1a). Here, CITED2 is linked to lung cancer.